Immunogenicity and safety evaluation of a newly manufactured recombinant Baculovirus-Expressed quadrivalent influenza vaccine in adults 18 years old and Above: An Open-Label, phase III extension study
Title:
Immunogenicity and safety evaluation of a newly manufactured recombinant Baculovirus-Expressed quadrivalent influenza vaccine in adults 18 years old and Above: An Open-Label, phase III extension study
Author:
Shahri, Mohammad Saleh Sadeghi, Setayesh Hazegh Fetratjoo, Delara Hosseini, Hamed Amin Ghobadi, Mohammad Afshani, Seyyedeh Maryam Mirhassani, Reihaneh Gohari, Kimiya Havasi, Forugh Abdolghaffari, Amirhossein Hedayatjoo, Behnaz Ghanei, Mostafa